USD 11.90 billion
Research Antibodies and Reagents Market Size, Share, Growth Analysis, By Technology(western blotting, flow cytometry, ELISA, Immunohistochemistry), By Application(proteomics, drug development and Genomics), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35H2053 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|Tables:
66
|Figures:
75
Research Antibodies and Reagents Market Insights
Global Research Antibodies and Reagents Market size was valued at USD 11.90 billion in 2022 and is poised to grow from USD 12.70 billion in 2023 to USD 21.33 billion by 2031, at a CAGR of 6.70% during the forecast period (2024-2031).
An unconjugated primary antibody that targets antigen is found using research antibodies and reagents. With the use of these items, proteins or biomolecules can be found, measured, and purified for use in a range of procedures, including flow cytometry, ELISA, western blotting, and immunohistochemistry. The rising demand for high-quality antibodies for research reproducibility is one of the key factors propelling the growth of the research antibodies and reagents market.
The expansion of proteomics and genomics research, as well as an increase in research and development activities to improve the overall course of diagnosis and treatment, are driving the growth of the research antibodies and reagents market. The increasing collaboration between industry and academia, as well as the growing stem cell and neurobiology research fields, all have an impact on the research antibodies and reagents market.
Furthermore, increased funding for research projects by for-profit and non-profit organisations, increased emphasis on biomarker discovery, government support, and growing interest in outsourcing all benefit the research antibodies and reagents market.
Furthermore, rising demand for personalized medicine and protein therapeutics, as well as emerging markets, provide profitable opportunities for research antibodies and reagents market players. On the other hand, cost and time-intensive antibody development processes, as well as pricing pressure on prominent players, are expected to stymie the growth of the research antibodies and reagents market. The research antibodies and reagents market is expected to face challenges from rising quality concerns and a lack of reproducible results during the forecast period.
US Research Antibodies and Reagents Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
proteomics
Fastest Growth
proteomics
Growth Rate
6.70% CAGR
research antibodies and reagents market, 2021-2030 ($ Bn)
Country Share for North America Region- 2021 (%)
To get more reports on the above market click here to Buy The Report
Research Antibodies and Reagents Market Segmental Analysis
The research antibodies and reagents market is segmented based on the technology, application and region. Based on technology, research antibodies and reagents market is segmented into western blotting, flow cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and other technologies. Based on application, the Research Antibodies and Reagents Market is segmented into proteomics, drug development and Genomics. Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.
Research Antibodies and Reagents Market Analysis by Technology
Based on technology, The segment for flow cytometry is anticipated to experience the largest increase during the course of the forecast. The growth of this market is being driven by elements like the benefits of this technique, its capacity to perform simultaneous multi-parameter analysis on single cells within a heterogeneous mixture, offering high throughput along with technological advancements in flow cytometry, and expanding oncology research.
Research Antibodies and Reagents Market Analysis by Application
Based on application, Proteomics has the most market share for research antibodies and reagents in 2021. factors like improved protein-protein and drug-protein interaction mapping efficiency. Proteomic technologies are also very effective and have reduced the cost, time, and resource requirements for drug manufacturing and biological testing. The market is being driven by such reasons.
research antibodies and reagents market By application, 2021 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Research Antibodies and Reagents Market Regional Insights
The market for research antibodies and reagents is dominated by North America due to an increase in investments for the creation of structure-based medication designs, a focus on research projects involving proteins, related biomolecules, and genes, and an expansion of research and development activities in the genomics and proteomics fields.
The market for research antibodies and reagents in Asia Pacific is anticipated to expand at the fastest CAGR. The market in the region is being driven by elements including expanding proteomics and genomics research, rising research funding, investments from pharmaceutical and biotechnology businesses, and rising regional awareness.
research antibodies and reagents market By geography, 2021-2030
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Research Antibodies and Reagents Market Dynamics
Research Antibodies and Reagents Market Drivers
Investment in R&D to Bolster Demand for Research Antibodies and Reagents
- Research and innovation depend on collaboration between academic institutions and the R&D departments of businesses. These partnerships guarantee the movement of information and technology from the academic world to the business world and vice versa. The number of such collaborations has greatly increased as a result of the escalating economic volatility and the quickening pace of technological change. Due to the numerous uses for research-specific antibodies, Reagents, market participants are concentrating on working with academic institutions to promote student and researcher awareness of new analytical technology.
Research Antibodies and Reagents Market Restraints
Different Conclusions to Hinder Market Growth
- The reproducibility dilemma, or the emerging recognition that many studies' results in biomedical research cannot be replicated and that conclusions based on them may be baseless, is largely brought on by variations in antibody quality. Results are not reproducible because of variations in antibody production methods. There are neither agreed-upon definitions of repeatability across all antibody offers nor standards for their validation.
Request Free Customization of this report to help us to meet your business objectives.
Research Antibodies and Reagents Market Competitive Landscape
the research antibodies and reagents market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.
Research Antibodies and Reagents Market Top Player's Company Profiles
- Thermo Fisher Scientific, Inc.
- Abcam plc.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Cell Signaling Technology, Inc.
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Santa Cruz Biotechnology, Inc.
- GE Healthcare Life Sciences
- BD Biosciences
- BioLegend, Inc.
- R&D Systems, Inc.
- Sigma-Aldrich Corporation
- Lonza Group Ltd.
- Promega Corporation
- Qiagen N.V.
- Affymetrix, Inc.
- Novus Biologicals, LLC
- Enzo Life Sciences, Inc.
- OriGene Technologies, Inc.
Research Antibodies and Reagents Market Recent Developments
- Located at Monash University in Malaysia, Agilent Technologies, Inc. (US) announced in August 2023 the inauguration of a new, full-scale Integrated Biology Center. The facility's main goal is to strengthen regional capacities for accelerating life science research and development (R&D).
- The definitive agreement for Danaher (US) to purchase all Abcam plc's (UK) outstanding shares was signed in August 2023. Abcam is anticipated to function as an independent business inside Danaher's Life Sciences division because of this development.
- Bio-Techne Corporation declared in July 2023 that the acquisition of Lunaphore had been completed. This decision was made with the intention of strengthening the companies' leadership in spatial biology within the domains of translational and clinical research.
- Cell Signaling Technology (CST) and Lunaphore announced their collaboration in June 2023. The goal of this project was to make it possible for Lunaphore to deploy CST antibodies on the COMET platform, bolstering fully automated spatial biology.
Research Antibodies and Reagents Key Market Trends
- Many diseases are now being detected, categorised, and treated differently thanks to personalised medicine, which has emerged as a key topic of research in the healthcare sector. In oncology, these developments are particularly noticeable. Additionally, over the past five years, biopharmaceutical companies have almost doubled their R&D expenditures in personalized medicine; during the following five, this expenditure is predicted to rise by 33%. Rapid, highly sensitive, and quantitative approaches to examine proteins and associated post-translational alterations in clinical specimens are now more important than ever as personalized medicine gains popularity and helps to define individual patient treatments. Additionally, because gene variants might predict a patient's propensity to respond to a certain medicine, researchers are concentrating on identifying and understanding different proteins. Changes, genetic variations, and their connection to various diseases.
Research Antibodies and Reagents Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our research antibodies and reagents market analysis, in terms of technology, the flow cytometry segment owing to its benefits and in terms of application, the Proteomics segment contribute to the market growth due to its high usage. Moreover, the Growing industry-academia collaboration is driving the market growth. Whereas Quality concerns and a lack of reproducible results can hamper the market growth.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 11.90 billion |
| Market size value in 2031 | USD 21.33 billion |
| Growth Rate | 6.70% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Research Antibodies and Reagents Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Research Antibodies and Reagents Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Research Antibodies and Reagents Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Research Antibodies and Reagents Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Research Antibodies and Reagents Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Research Antibodies and Reagents Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
